BPC 157: Experimental Peptide Creates Risk for Athletes Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Approval: Economics, Not Science? Unpacking the System The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Banned? Oral vs. Injectable Forms Explained